86 related articles for article (PubMed ID: 17653449)
21. HIV infection and zidovudine use in childbearing women.
Sia J; Paul S; Martin RM; Cross H
Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
[TBL] [Abstract][Full Text] [Related]
22. Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.
Suksomboon N; Poolsup N; Ket-Aim S
J Clin Pharm Ther; 2007 Jun; 32(3):293-311. PubMed ID: 17489882
[TBL] [Abstract][Full Text] [Related]
23. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.
Peters V; Liu KL; Dominguez K; Frederick T; Melville S; Hsu HW; Ortiz I; Rakusan T; Gill B; Thomas P
Pediatrics; 2003 May; 111(5 Pt 2):1186-91. PubMed ID: 12728136
[TBL] [Abstract][Full Text] [Related]
24. The efficacy and tolerability of combination antiretroviral therapy in pregnancy: infant and maternal outcome.
Clarke SM; Mulcahy F; Healy CM; Condon S; Butler KM
Int J STD AIDS; 2000 Apr; 11(4):220-3. PubMed ID: 10772084
[TBL] [Abstract][Full Text] [Related]
25. Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero.
Olivero OA; Shearer GM; Chougnet CA; Kovacs AA; Landay AL; Baker R; Stek AM; Khoury MM; Proia LA; Kessler HA; Sha BE; Tarone RE; Poirier MC
AIDS; 1999 May; 13(8):919-25. PubMed ID: 10371172
[TBL] [Abstract][Full Text] [Related]
26. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
27. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.
Brogly SB; Ylitalo N; Mofenson LM; Oleske J; Van Dyke R; Crain MJ; Abzug MJ; Brady M; Jean-Philippe P; Hughes MD; Seage GR
AIDS; 2007 May; 21(8):929-38. PubMed ID: 17457086
[TBL] [Abstract][Full Text] [Related]
28. Elevated Levels of Estradiol in Human Immunodeficiency Virus-Infected Pregnant Women on Protease Inhibitor-Based Regimens.
Balogun KA; Guzman Lenis MS; Papp E; Loutfy M; Yudin MH; MacGillivray J; Walmsley SL; Silverman M; Serghides L
Clin Infect Dis; 2018 Jan; 66(3):420-427. PubMed ID: 29020282
[TBL] [Abstract][Full Text] [Related]
29. Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.
Bhana N; Ormrod D; Perry CM; Figgitt DP
Paediatr Drugs; 2002; 4(8):515-53. PubMed ID: 12126455
[TBL] [Abstract][Full Text] [Related]
30. Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy.
Kakehasi FM; Tupinambás U; Cleto S; Aleixo A; Lin E; Melo VH; Aguiar RA; Pinto JA
AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1515-20. PubMed ID: 18160009
[TBL] [Abstract][Full Text] [Related]
31. Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine.
Baroncelli S; Pinnetti C; Genovese O; Tamburrini E; Floridia M
J Med Virol; 2011 Mar; 83(3):551-6. PubMed ID: 21264878
[TBL] [Abstract][Full Text] [Related]
32. A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study).
Podzamczer D; Ferrer E; Consiglio E; Gatell JM; Perez P; Perez JL; Luna E; González A; Pedrol E; Lozano L; Ocaña I; Llibre JM; Casiró A; Aranda M; Barrufet P; Martínez-Lacasa J; Miró JM; Badía X; Casado A; Lupo S; Cahn P; Maños M; Estela J
Antivir Ther; 2002 Jun; 7(2):81-90. PubMed ID: 12212928
[TBL] [Abstract][Full Text] [Related]
33. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
[TBL] [Abstract][Full Text] [Related]
34. Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine.
Rough K; Seage GR; Williams PL; Hernandez-Diaz S; Huo Y; Chadwick EG; Currier JS; Hoffman RM; Barr E; Shapiro DE; Patel K;
N Engl J Med; 2018 Apr; 378(17):1593-1603. PubMed ID: 29694825
[TBL] [Abstract][Full Text] [Related]
35. Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.
Chung MH; Kiarie JN; Richardson BA; Lehman DA; Overbaugh J; Kinuthia J; Njiri F; John-Stewart GC
Antivir Ther; 2008; 13(6):799-807. PubMed ID: 18839781
[TBL] [Abstract][Full Text] [Related]
36. Reduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmission.
Kuhn L; Meddows-Taylor S; Gray G; Trabattoni D; Clerici M; Shearer GM; Tiemessen C
Clin Exp Immunol; 2001 Mar; 123(3):443-50. PubMed ID: 11298132
[TBL] [Abstract][Full Text] [Related]
37. Rash, hepatotoxicity and hyperbilirubinemia among Kenyan infants born to HIV-infected women receiving triple-antiretroviral drugs for the prevention of mother-to-child HIV transmission.
Minniear TD; Zeh C; Polle N; Masaba R; Peters PJ; Oyaro B; Akoth B; Ndivo R; Angira F; Mills LA; Thomas TK
Pediatr Infect Dis J; 2012 Nov; 31(11):1155-7. PubMed ID: 22772167
[TBL] [Abstract][Full Text] [Related]
38. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
[TBL] [Abstract][Full Text] [Related]
39. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.
Divi RL; Leonard SL; Kuo MM; Nagashima K; Thamire C; St Claire MC; Wade NA; Walker VE; Poirier MC
Environ Mol Mutagen; 2007; 48(3-4):201-9. PubMed ID: 16538687
[TBL] [Abstract][Full Text] [Related]
40. Preventive antiretroviral therapy in non-thalassemia carrier infants exposed to mother-to-child transmission of HIV decreases cord and after delivery red blood production without altering the development of hemoglobin.
Pornprasert S; Wongnoi R; Oberdorfer P; Sirivatanapa P
Curr HIV Res; 2014; 12(3):227-31. PubMed ID: 25026900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]